Inactive Instrument

News Camson Bio Technologies Limited

Equities

538858

INE845E01012

Summary

Unlock all the news: Be the first to know and act before the market!

Camson Bio Technologies Limited Announces Board Changes	16/19/16	CI
Camson Bio Technologies Limited Announces Resignation of Karan Singh as Director	30/19/30	CI
Camson Bio Technologies Limited Announces Resignation of Chandra Prakash Sharma as Chief Financial Officer	26/19/26	CI
Camson Bio Technologies Limited Appoints Karan Singh as Director	25/19/25	CI
Camson Bio Technologies Limited Announces Audited Earnings Results for the Fourth Quarter and Full Year for the Year Ended March 31, 2019	23/19/23	CI
Akbal Narayan Singh Resigns as Non-Executive Director of Camson Bio Technologies Limited	21/19/21	CI
Camson Bio Technologies Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2019	12/19/12	CI
Camson Bio Technologies Limited Appoints Dhirendra Kumar as the Compliance Officer	25/19/25	CI
Camson Bio Technologies Limited Announces Resignation of Arundeo Prasad Singh as Additional Director and an Independent Director	23/19/23	CI
Camson Bio Technologies Limited Announces Resignation of Vinod Kumar Lahoti as Independent Director	19/19/19	CI
Camson Bio Technologies Limited Announces Unaudited Standalone Earnings Results for the Fourth Quarter and Full Year for the Year Ended March 31, 2019	29/19/29	CI
Camson Bio Technologies Limited Appoints Arundeo Prasad Singh as an Additional Independent Director	29/19/29	CI
Camson Bio Technologies Limited Announces Resignation of Goonj Rastogi as Company Secretary and Compliance Officer	14/19/14	CI
Camson Bio Technologies Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2018	12/19/12	CI
Camson Bio Technologies Limited Announces Executive Appointments	12/19/12	CI
GLOBAL MARKETS LIVE: Fedex, J&J, SoftBank, GE…	19/18/19
Camson Bio Technologies Limited Announces Unaudited Standalone Earnings Results for the Second Quarter and Half Year Ended September 30, 2018	15/18/15	CI
Camson Bio Technologies Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2018	13/18/13	CI
Camson Bio Technologies Limited Approves Resignation of Declan Pearse Macfadden as Independent Director	13/18/13	CI
Camson Bio Technologies Limited Announces Resignation of Declan Pearse Maefadden as Independent Director	25/18/25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Camson Bio Technologies Limited

Equities

538858

INE845E01012

Summary

Filters